tranexamic acid has been researched along with lisinopril in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jackson, CL; Reidy, MA | 1 |
Geiger, H; McMahon, A; Wang, K | 1 |
Azmaiparashvili, Z; Lo, KB; Martinez Manzano, JM; Patarroyo-Aponte, G | 1 |
1 review(s) available for tranexamic acid and lisinopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for tranexamic acid and lisinopril
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
The role of plasminogen activation in smooth muscle cell migration after arterial injury.
Topics: Animals; Antihypertensive Agents; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cell Movement; Dipeptides; Fibrinolysin; In Vitro Techniques; Kinetics; Lisinopril; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Plasminogen Activator; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1992 |
Tranexamic acid for ACE inhibitor induced angioedema.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antifibrinolytic Agents; Female; Humans; Lisinopril; Middle Aged; Tranexamic Acid | 2021 |
The use of intravenous tranexamic acid for patients with angiotensin-converting enzyme inhibitor-induced angioedema: A case series.
Topics: Administration, Intravenous; Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antifibrinolytic Agents; Female; Humans; Lisinopril; Male; Middle Aged; Tranexamic Acid | 2021 |